Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan

被引:1
作者
Mitsutake, Kotaro [1 ]
Shinya, Natsuki [1 ]
Seki, Masafumi [1 ,2 ]
Ohara, Takahiro [3 ]
Uemura, Kohei [4 ]
Fukunaga, Masato [5 ]
Sakai, Jun [6 ]
Nagao, Miki [7 ]
Sata, Makoto [8 ]
Hamada, Yohei [9 ]
Kawasuji, Hitoshi [10 ]
Yamamoto, Yoshihiro [10 ]
Nakamatsu, Masashi [11 ]
Koizumi, Yusuke [12 ]
Mikamo, Hiroshige [12 ]
Ukimura, Akira [13 ,14 ]
Aoyagi, Tetsuji
Sawai, Toyomitsu [15 ]
Tanaka, Takeshi [16 ]
Izumikawa, Koichi [16 ]
Takayama, Yoko [17 ]
Nakamura, Kiwamu [18 ]
Kanemitsu, Keiji [18 ]
Tokimatsu, Issei [19 ]
Nakajima, Kazuhiko [20 ]
Akine, Dai [21 ]
机构
[1] Saitama Med Univ, Saitama Int Med Ctr, Dept Infect Dis & Infect Control, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan
[2] Tohoku Med & Pharmaceut Univ, Fac Med, Dept Infect Dis, 1-15-1 Fukumuro,Miyagino Ku, Sendai, Miyagi 9838536, Japan
[3] Tohoku Med & Pharmaceut Univ, Div Geriatr & Community Med, 1-15-1 Fukumuro,Miyagino ku, Sendai, Miyagi 9838536, Japan
[4] Univ Tokyo, Dept Biostat & Bioinformat, Interfac Initiat Informat Studies, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan
[5] Kokura Mem Hosp, Dept Cardiol, 3-2-1 Asano,Kokurakita Ku, Kitakyushu, Fukuoka 8028555, Japan
[6] Saitama Med Univ Hosp, Dept Infect Dis & Infect Control, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan
[7] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto, Kyoto 6068507, Japan
[8] Natl Cerebral & Cardiovasc Ctr, Div Pulmonol & Infect Control, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan
[9] Saga Univ Hosp, Div Infect Dis & Hosp Epidemiol, 5-1-1 Nabeshima, Saga 8490937, Japan
[10] Toyama Univ, Dept Clin Infect Dis, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama, Toyama 9300194, Japan
[11] Univ Ryukyus Hosp, Dept Infect Control, 207 Aza Uehara, Nishihara, Okinawa 9030215, Japan
[12] Aichi Med Univ, Dept Clin Infect Dis, 1-1 Iwasaku, Nagakute, Aichi 4801195, Japan
[13] Osaka Med & Pharmaceut Univ Hosp, Infect Control Ctr, 2-7 Daigaku Cho, Takatsuki, Osaka 5690801, Japan
[14] Tohoku Univ, Dept Clin Microbiol & Infect, Dept Comprehens Infect Dis, Grad Sch Med, 2-1 Seiryo cho,Aoba ku, Sendai 9808575, Japan
[15] Nagasaki Harbor Med Ctr, Dept Resp Med, 6-39 Shinchi cho, Nagasaki, Nagasaki 8500842, Japan
[16] Nagasaki Univ Hosp, Infect Control & Educ Ctr, 1 Chome-7-1 Sakamoto, Nagasaki 8528501, Japan
[17] Kitasato Univ, Res & Dev Ctr New Med Frontiers, Dept Infect Control & Infect Dis, Sch Med, 1-15-1 Kitazato,Minami Ku, Sagamihara, Kanagawa 2520374, Japan
[18] Fukushima Med Univ, Dept Infect Control, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan
[19] Showa Univ, Dept Med, Div Clin Infect Dis, Sch Med, 1-5-8 Hatanodai,Shinagawa ku, Tokyo 1428666, Japan
[20] Hyogo Med Univ, Dept Infect Prevent & Control, 1-1 Mukogawa, Nishinomiya, Hyogo 663850, Japan
[21] Jichi Med Univ, Sch Med, Div Clin Infect Dis, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
关键词
Endocarditis; Methicillin-resistant Staphylococcus aureus; Prognosis; Multi-organ failure; Surgical treatment; DISEASE REGISTRATION CADRE; INFECTIVE ENDOCARDITIS; SURGERY; ASSOCIATION; DAPTOMYCIN; VANCOMYCIN; DIAGNOSIS; IMPACT; GUIDELINES; MANAGEMENT;
D O I
10.1016/j.jiac.2024.06.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) ) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan and identify the factors associated with prognosis. Methods: This retrospective study included patients with a confirmed diagnosis of IE caused by MRSA, between January 2015 and April 2019. Results: A total of 65 patients from 19 centers were included, with a mean age of 67 years and 26 % were female. Fifty percent of the patients with IE were had nosocomial infections and 25 % had prosthetic valve involvement.The most common comorbidities were hemodialysis (20 %) and diabetes (20 %). Congestive heart failure was present in 86 % of patients (NYHA class I, II: 48 %; III, IV: 38 %). The 30-day and in-hospital mortality rates were 29 % and 46 %, respectively. Multi-organ failure was the primary cause of death, accounting for 43 % of all causes of death. Prognostic factors for in-hospital mortality were age, disseminated intravascular coagulation, daptomycin and/or linezolid as initial antibiotic therapy, and surgery. Surgical treatment was associated with lower mortality rate (odds ratio [OR], 0.026; 95 % confidence interval [CI], 0.002-0.382; p = 0.008 for 30-day mortality and OR, 0.130; 95 % CI; 0.029-0.584; p = 0.008 for in-hospital mortality). Conclusion: Mortality due to MRSA-IE remains high. Surgical treatment is a significant prognostic predictor MRSA-IE.
引用
收藏
页码:1259 / 1265
页数:7
相关论文
共 33 条
  • [1] Comparison of prognoses of Staphylococcus aureus left-sided prosthetic endocarditis and prosthetic endocarditis caused by other pathogens
    Abdallah, Layal
    Habib, Gilbert
    Remadi, Jean-Paul
    Salaun, Erwan
    Casalta, Jean-Paul
    Tribouilloy, Christophe
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (10) : 542 - 549
  • [2] Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012)
    Ambrosioni, Juan
    Hernandez-Meneses, Marta
    Durante-Mangoni, Emanuele
    Tattevin, Pierre
    Olaison, Lars
    Freiberger, Tomas
    Hurley, John
    Hannan, Margaret M.
    Chu, Vivian
    Hoen, Bruno
    Moreno, Asuncion
    Cuervo, Guillermo
    Llopis, Jaume
    Miro, Jose M.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (04) : 1083 - 1101
  • [3] Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
    Baddour, Larry M.
    Wilson, Walter R.
    Bayer, Arnold S.
    Fowler, Vance G., Jr.
    Tleyjeh, Imad M.
    Rybak, Michael J.
    Barsic, Bruno
    Lockhart, Peter B.
    Gewitz, Michael H.
    Levison, Matthew E.
    Bolger, Ann F.
    Steckelberg, James M.
    Baltimore, Robert S.
    Fink, Anne M.
    O'Gara, Patrick
    Taubert, Kathryn A.
    [J]. CIRCULATION, 2015, 132 (15) : 1435 - 1486
  • [4] Benito DN, 2013, Health care-associated native valve endocarditis in patients with no history of injection drug use: current importance of non-nosocomial acquisition
  • [5] Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry
    Bohbot, Yohann
    Habib, Gilbert
    Laroche, Cecile
    Stohr, Elisabeth
    Chirouze, Catherine
    Hernandez-Meneses, Marta
    Melissopoulou, Maria
    Mutlu, Bulent
    Scheggi, Valentina
    Branco, Luisa
    Olmos, Carmen
    Reyes, Graciela
    Pazdernik, Michal
    Iung, Bernard
    Sow, Rouguiatou
    Mirocevic, Maja
    Lancellotti, Patrizio
    Tribouilloy, Christophe
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (07) : 1253 - 1265
  • [6] Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis
    Casapao, Anthony M.
    Lodise, Thomas P.
    Davis, Susan L.
    Claeys, Kimberly C.
    Kullar, Ravina
    Levine, Donald P.
    Rybak, Michael J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 2978 - 2985
  • [7] Impact of a Multidisciplinary Management Strategy on the Outcome of Patients With Native Valve Infective Endocarditis
    Chirillo, Fabio
    Scotton, Piergiorgio
    Rocco, Francesco
    Rigoli, Roberto
    Borsatto, Francesca
    Pedrocco, Alessandra
    De Leo, Alessandro
    Minniti, Giuseppe
    Polesel, Elvio
    Olivari, Zoran
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (08) : 1171 - 1176
  • [8] Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus
    Dailey, CF
    Dileto-Fang, CL
    Buchanan, LV
    Oramas-Shirey, MP
    Batts, DH
    Ford, CW
    Gibson, JK
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) : 2304 - 2308
  • [9] Endocarditis Caused by Staphylococcus aureus A Reappraisal of the Epidemiologic, Clinical, and Pathologic Manifestations With Analysis of Factors Determining Outcome
    Fernandez Guerrero, Manuel L.
    Gonzalez Lopez, Julio J.
    Goyenechea, Ana
    Fraile, Julian
    de Gorgolas, Miguel
    [J]. MEDICINE, 2009, 88 (01) : 1 - 22
  • [10] Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    Fowler, Vance G., Jr.
    Boucher, Helen W.
    Corey, G. Ralph
    Abrutyn, Elias
    Karchmer, Adolf W.
    Rupp, Mark E.
    Levine, Donald P.
    Chambers, Henry F.
    Tally, Francis P.
    Vigliani, Gloria A.
    Cabell, Christopher H.
    Link, Arthur Stanley
    DeMeyer, Ignace
    Filler, Scott G.
    Zervos, Marcus
    Cook, Paul
    Parsonnet, Jeffrey
    Bernstein, Jack M.
    Price, Connie Savor
    Forrest, Graeme N.
    Faetkenheuer, Gerd
    Gareca, Marcelo
    Rehm, Susan J.
    Brodt, Hans Reinhardt
    Tice, Alan
    Cosgrove, Sara E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07) : 653 - 665